SCHEMBL21907779

SCHEMBL21907779

Cc1cn(CCC(F)Cn2cc(C(=O)NCc3cc(C(F)(F)F)ccn3)nn2)nn1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GLS O94925 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17419714 0.95 GLS (0.91) GLS
SCHEMBL29752915 0.95 GLS (0.91) GLS
SCHEMBL17411595 0.93 GLS (0.86) GLS
SCHEMBL29753027 0.92 GLS (1.00) GLS
SCHEMBL17396704 0.92 GLS (1.00) GLS
SCHEMBL17412040 0.92 GLS (1.00) GLS
SCHEMBL17419954 0.92 GLS (1.00) GLS
SCHEMBL17411710 0.91 GLS (0.86) GLS
SCHEMBL17411702 0.91 GLS (0.84) GLS
SCHEMBL17411944 0.91 GLS (0.84) GLS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3677579-A1 HETEROCYCLIC GLS1 INHIBITORS Board of Regents, The University of Texas System (US) 2020-07-08 — — EP disclosed
EP-3164394-B1 GLS1 INHIBITORS FOR TREATING DISEASES UNIV TEXAS (US) 2020-04-01 — — EP disclosed
Send feedback